Loading page...
Loading page...
Sofinnova Partners is a life sciences venture capital firm based in Paris, investing at Series A and Series B in healthcare, biotech and medtech. Its Capital XI fund closed at around EUR 650M in 2025 to back 50 to 60 early-stage companies across Europe and North America, and the firm is backed by the EIF.
Choose your AI and follow the walkthrough. Your free EUACC account connects the two.
Illustrated walkthrough
https://www.euacc.ai/api/mcpWorks on every Claude plan, including Free (one custom connector). On Team and Enterprise, an Owner adds it.
On a phone, add it at claude.ai in your browser. It then shows up in the Claude app the next time you sign in.
Use EUACC to explore “Sofinnova partners” (https://www.euacc.ai/investors/sofinnova-partners). Help me assess investor fit and prepare questions using the available fund profiles. Cite the available sources and flag missing or outdated information.